FIBRISTAL (ulipristal acetate) Withdrawal in Canada due to Risk of Liver Injury

Allergan Inc. has decided to withdraw the drug Fibristal (ulipristal acetate), used to treat uterine fibroids, from the Canadian market. Allergan made this decision in response to a number of international cases of serious liver injury requiring liver transplantation.